About this medicine
- Approved name
- Cozaar
- International non-proprietary name (INN) or common name
- irbesartan
- Associated names
- Loortan
- Loortan Cardio Start
- Cozaar Startpakkle
- Cardopal Start
- Lorzaar
- Lorzaar start
- Lorzaar Protect
- Pinzaar
- Lorzaar Varipharmstart
- Lortaan
- Neo-Lotan
- Losaprex
- Cozaar IC
- Lortaar IC
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-29 PAD/1022
- Type
- Article 29 paediatrics
This type of procedure may be triggered by a marketing-authorisation holder when applying for a new indication, new pharmaceutical form or new route of administration for use in children for a product authorised under Directive 2001/83/EC.
Key dates and outcomes
- CHMP opinion date
- 23/10/2008
- EC decision date
- 22/01/2009